Drug therapy in the heart transplant recipient: Part IV: Drug-drug interactionsPAGE, Robert L; MILLER, Geraldine G; LINDENFELD, Joann et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 2, pp 230-239, issn 0009-7322, 10 p.Article

Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipientBISOGNANO, John D; LINDENFELD, Joann; HAMMOND, Elizabeth et al.The Journal of heart and lung transplantation. 2005, Vol 24, Num 3, pp 355-358, issn 1053-2498, 4 p.Article

Post-pericardial injury syndrome after continuous-flow ventricular assistanceHEATH, Russell; BRETT REECE, T; SHAKAR, Simon et al.The Journal of heart and lung transplantation. 2011, Vol 30, Num 6, pp 726-729, issn 1053-2498, 4 p.Article

Longitudinal left ventricular structural and functional imaging during full support with continuous-flow ventricular assist devices: A retrospective, preliminary analysisAMBARDEKAR, Amrut V; DOROSZ, Jennifer L; CLEVELAND, Joseph C et al.The Journal of heart and lung transplantation. 2012, Vol 31, Num 12, pp 1311-1313, issn 1053-2498, 3 p.Article

Effect of Lovastatin on Primary Prevention of Cardiovascular Events in Mild CKD and Kidney Function Loss: A Post Hoc Analysis of the Air Force/Texas Coronary Atherosclerosis Prevention StudyKENDRICK, Jessica; SHLIPAK, Michael G; TARGHER, Giovanni et al.American journal of kidney diseases. 2010, Vol 55, Num 1, pp 42-49, issn 0272-6386, 8 p.Article

Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiencyCHONCHOL, Michel; COOK, Thomas; KJEKSHUS, John et al.American journal of kidney diseases. 2007, Vol 49, Num 3, pp 373-382, issn 0272-6386, 10 p.Article

Developing a Cardiology-Oncology Clinical Practice GuidelineLINDENFELD, Joann; KELLY, Patricia A.Progress in cardiovascular diseases. 2010, Vol 53, Num 2, pp 173-179, issn 0033-0620, 7 p.Article

Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockersLINDENFELD, Joann; ROBERTSON, Alastair D; LOWES, Brian D et al.Journal of the American College of Cardiology. 2001, Vol 38, Num 7, pp 1950-1956, issn 0735-1097Article

Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteriesLINDENFELD, Joann; KELLER, Karin; CAMPBELL, David N et al.The Journal of heart and lung transplantation. 2003, Vol 22, Num 2, pp 198-201, issn 1053-2498, 4 p.Article

Pharmacokinetic drug-drug interactions between calcineurin inhibitors and proliferation signal inhibitors with anti-microbial agents: Implications for therapeutic drug monitoringPAGE, Robert L; MUELLER, Scott W; LEVI, Marilyn E et al.The Journal of heart and lung transplantation. 2011, Vol 30, Num 2, pp 124-135, issn 1053-2498, 12 p.Article

Regulation of oxygen delivery during induced polycythemia in exercising dogsLINDENFELD, Joann; WEIL, John V; TRAVIS, Victoria L et al.American journal of physiology. Heart and circulatory physiology. 2005, Vol 58, Num 5, pp H1821-H1825, issn 0363-6135Article

Cardiovascular risk in women with type 2 diabetesBRANDENBURG, Suzanne L; LINDENFELD, Joann; REUSCH, Jane E. B et al.The Medical clinics of North America. 2003, Vol 87, Num 5, issn 0025-7125, viii, 955-969 [15 p.]Article

Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failurePETERSON, Pamela N; MAGID, David J; LYONS, Ella E et al.The American heart journal. 2010, Vol 159, Num 1, pp 81-89, issn 0002-8703, 9 p.Article

Outcomes by gender in the African-American heart failure trialTAYLOR, Anne L; LINDENFELD, Joann; COHN, Jay N et al.Journal of the American College of Cardiology. 2006, Vol 48, Num 11, pp 2263-2267, issn 0735-1097, 5 p.Article

Drug therapy in the heart transplant recipient. Part II: Immunosuppressive drugsLINDENFELD, Joann; MILLER, Geraldine G; SHAKAR, Simon F et al.Circulation (New York, N.Y.). 2004, Vol 110, Num 25, pp 3858-3865, issn 0009-7322, 8 p.Article

Mode of death in advanced heart failure : The comparison of medical, pacing, and defibrillation therapies in heart failure (COMPANION) trialCARSON, Peter; ANAND, Inder; BRISTOW, Michael R et al.Journal of the American College of Cardiology. 2005, Vol 46, Num 12, pp 2329-2334, issn 0735-1097, 6 p.Article

The effect of Diabetes on outcomes of Patients with advanced heart failure in the BEST trialDOMANSKI, Michael; KRAUSE-STEINRAUF, Heidi; MARTIN, Wade et al.Journal of the American College of Cardiology. 2003, Vol 42, Num 5, pp 914-922, issn 0735-1097, 9 p.Article

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agentsLOWES, Brian D; GILBERT, Edward M; QUAIFE, Robert A et al.The New England journal of medicine. 2002, Vol 346, Num 18, pp 1357-1365, issn 0028-4793Article

Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitorsSTEINGART, Richard M; BAKRIS, George L; MAITLAND, Michael L et al.The American heart journal. 2012, Vol 163, Num 2, pp 156-163, issn 0002-8703, 8 p.Article

Mode of Death and Hospitalization from the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) Trial and Comparison of Clinical Events Committee Adjudicated Versus Investigator Reported OutcomesO'CONNOR, Christopher M; FIUZAT, Mona; YANCY, Clyde et al.The American journal of cardiology. 2011, Vol 108, Num 10, pp 1449-1457, issn 0002-9149, 9 p.Article

Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist deviceAMBARDEKAR, Amrut V; ALLEN, Larry A; LINDENFELD, Joann et al.The Journal of heart and lung transplantation. 2010, Vol 29, Num 7, pp 771-776, issn 1053-2498, 6 p.Article

Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure : Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) TrialANAND, Inder S; CARSON, Peter; LEIGH, Jill et al.Circulation (New York, N.Y.). 2009, Vol 119, Num 7, pp 969-977, issn 0009-7322, 9 p.Article

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with new york heart association functional class I or II heart failure. CommentaryDARGIE, Henry J; HILDEBRANDT, Per R; RIEGGER, Günter A. J et al.Journal of the American College of Cardiology. 2007, Vol 49, Num 16, pp 1696-1707, issn 0735-1097, 12 p.Article

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York heart association class IV heart failureLINDENFELD, Joann; FELDMAN, Arthur M; DEMARCO, Teresa et al.Circulation (New York, N.Y.). 2007, Vol 115, Num 2, pp 204-212, issn 0009-7322, 9 p.Article

Assist Devices Fail to Reverse Patterns of Fetal Gene Expression Despite β-BlockersLOWES, Brian D; ZOLTY, Ronald; GERACI, Mark et al.The Journal of heart and lung transplantation. 2007, Vol 26, Num 11, pp 1170-1176, issn 1053-2498, 7 p.Article